Shilpa Medicare · NSE: SHILPAMED · BSE: 530549
Q3 FY21 results · Oct–Dec 2020
Shilpa Medicare reported revenue from operations of ₹191.25 crore (down 19.3% from Q3 FY20) and net profit of ₹7.67 crore (down 86.0% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 191.25 | 236.85 | −19.3% | 278.94 | −31.4% |
| Other income | 8.61 | 3.25 | +164.5% | 9.20 | −6.5% |
| Total income | 199.85 | 240.11 | −16.8% | 288.14 | −30.6% |
| Profit before tax | 10.58 | 64.76 | −83.7% | 61.23 | −82.7% |
| Net profit for the period | 7.67 | 54.92 | −86.0% | 45.21 | −83.0% |
| EPS, basic (₹) | 0.94 | 6.75 | −86.1% | 5.57 | −83.1% |
| Net margin (%) | 4.0 | 23.2 | 16.2 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 171.30 | 216.93 | −21.0% | 262.68 | −34.8% |
| Other income | 8.61 | 2.47 | +248.9% | 7.52 | +14.4% |
| Total income | 179.91 | 219.40 | −18.0% | 270.20 | −33.4% |
| Profit before tax | 24.87 | 68.67 | −63.8% | 75.72 | −67.2% |
| Net profit for the period | 16.88 | 56.61 | −70.2% | 54.78 | −69.2% |
| EPS, basic (₹) | 2.07 | 6.94 | −70.2% | 6.72 | −69.2% |
| Net margin (%) | 9.9 | 26.1 | 20.9 |
Consolidated
- Filed with BSE
- 13 Feb 2021, 18:49 IST
- Board meeting
- 13 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Feb 2021, 18:49 IST
- Board meeting
- 13 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE